WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke LIPTIDE wurde als Wortmarke am 30.07.2018 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1428875 |
| Länder | 
|
| Basismarke |
Nr. UK00003321897,
02. Juli 2018
|
| Anmeldedatum | 30. Juli 2018 |
| Ablaufdatum | 30. Juli 2028 |
Markeninhaber
2nd Floor, 2 Woodberry Grove
London N12 0DR
GB
London N12 0DR
GB
Markenvertreter
310 St. Vincent Street
Glasgow G2 5RG
GB
Waren und Dienstleistungen
05
Pharmaceutical preparations and substances; chemicals for
pharmaceutical use; pharmaceuticals and pharmaceutical
preparations being nanoparticles; pharmaceuticals and
pharmaceutical preparations containing siRNA;
pharmaceuticals and pharmaceutical preparations containing
RNA; pharmaceuticals and pharmaceutical preparations
containing shRNA; pharmaceuticals and pharmaceutical
preparations containing mRNA; pharmaceuticals and
pharmaceutical preparations containing DNA; drug delivery
agents being made from lipids, liposomes or peptides;
pharmaceuticals and pharmaceutical preparations containing
lipids, liposomes or peptides; drug delivery agents; drug
delivery agents that facilitate the delivery of
pharmaceuticals and pharmaceutical preparations; intravenous
fluids used for rehydration, nutrition and the delivery of
pharmaceutical preparations; pharmaceutical and drug
delivery agents for use in relation to the delivery of
siRNA, shRNA, mRNA, RNA, DNA or other genetic material;
preparations for detecting genetic predispositions for
medical purposes; pharmaceuticals and pharmaceutical
preparations for use in gene therapy; drug delivery agents
for use in gene therapy; drug delivery agents being
nanoparticles; pharmaceutical and natural remedies; medical
preparations; biochemical preparation for medical purposes;
biological preparations for medical purposes; reagents for
medical use; reagents for use in medical genetic testing;
anti-cancer preparations; anti-cancer drugs; compounds for
treating cancer; biopharmaceuticals for the treatment of
cancer; anti-cancer preparations of chemical origin;
anti-cancer preparations of plant origin; anti-cancer
preparations of microbial origin; pharmaceutical
preparations for the treatment of cancer; pharmaceutical
products for the treatment of cancer; biological
preparations for the treatment of cancer; anti-cancer
preparations from hormones and antagonists; pharmaceutical
preparations and substances for the prevention of cancer;
chemotherapeutics; pharmaceutical preparations for use in
chemotherapy; pharmaceutical preparations and substances for
use in oncology; pharmaceutical preparations for the
treatment and prevention of tumours
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 15. Oktober 2020 | 2020/42 Gaz | JP | Ablehnung |
| 08. September 2020 | 2020/37 Gaz | US | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 15. März 2020 | 2020/36 Gaz | KR | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 24. Oktober 2019 | 2019/43 Gaz | JP | Ablehnung |
| 13. September 2019 | 2020/6 Gaz | MX | Ablehnung |
| 24. Juni 2019 | 2019/26 Gaz | KR | Ablehnung |
| 25. März 2019 | 2019/13 Gaz | EM | Ablehnung |
| 30. Januar 2019 | 2019/6 Gaz | CN | Ablehnung |
| 07. Dezember 2018 | 2018/50 Gaz | US | Ablehnung |
| 30. Juli 2018 | 2018/40 Gaz | GB | Eintragung |
ID: 141428875